$3.43 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 93 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 58.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $280,641,000 | +66.3% | 144,832,000 | 0.0% | 8.17% | +52.7% | ||
| MYL | MYLAN NV | $195,394,000 | +7.8% | 12,151,362 | 0.0% | 5.69% | -1.0% | |
| NEVRO CORPnote 1.750% 6/0 | $157,797,000 | +17.8% | 115,776,000 | 0.0% | 4.60% | +8.1% | ||
| SDGR | SCHRODINGER INC | $123,269,000 | +112.4% | 1,346,167 | 0.0% | 3.59% | +94.9% | |
| DFPHU | DFP HEALTHCARE ACQUISITNS COunit 03/31/2025 | $111,661,000 | +8.4% | 10,460,000 | 0.0% | 3.25% | -0.6% | |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $108,448,000 | -37.8% | 1,951,211 | -66.9% | 3.16% | -42.9% |
| New | NUVASIVE INCnote 2.250% 3/1 | $93,062,000 | – | 85,000,000 | +100.0% | 2.71% | – | |
| IMMU | Sell | IMMUNOMEDICS INC | $90,762,000 | +63.9% | 2,561,000 | -37.7% | 2.64% | +50.4% |
| PCRX | Buy | PACIRA BIOSCIENCES | $87,258,000 | +59.9% | 1,663,000 | +2.2% | 2.54% | +46.7% |
| New | DEXCOM INCnote 0.750%12/0 | $84,346,000 | – | 34,000,000 | +100.0% | 2.46% | – | |
| HOLX | New | HOLOGIC INC | $78,101,000 | – | 1,370,186 | +100.0% | 2.27% | – |
| MYOK | Buy | MYOKARDIA INC | $68,020,000 | +318.8% | 704,000 | +103.2% | 1.98% | +284.7% |
| MIRM | MIRUM PHARMACEUTICALS INC | $67,116,000 | +39.0% | 3,448,912 | 0.0% | 1.96% | +27.6% | |
| LRMR | New | LARIMAR THERAPEUTICS INC | $66,107,000 | – | 5,144,539 | +100.0% | 1.92% | – |
| New | INSMED INCnote 1.750% 1/1 | $59,326,000 | – | 61,000,000 | +100.0% | 1.73% | – | |
| RVMD | REVOLUTION MEDICINES INC | $56,712,000 | +44.1% | 1,796,383 | 0.0% | 1.65% | +32.3% | |
| CNC | Sell | CENTENE CORP DEL | $56,305,000 | -25.2% | 886,000 | -30.1% | 1.64% | -31.4% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $55,081,000 | +19.4% | 2,470,013 | -18.5% | 1.60% | +9.6% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $51,839,000 | +143.6% | 1,234,262 | +56.6% | 1.51% | +123.7% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $49,456,000 | +8.5% | 1,408,603 | -21.5% | 1.44% | -0.5% |
| CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $44,037,000 | +1.0% | 49,064,000 | 0.0% | 1.28% | -7.3% | ||
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $43,560,000 | -34.7% | 7,259,988 | -18.1% | 1.27% | -40.1% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $43,410,000 | -7.3% | 57,791,000 | 0.0% | 1.26% | -14.9% | ||
| MCK | Buy | MCKESSON CORP | $42,664,000 | +79.8% | 278,085 | +58.5% | 1.24% | +64.9% |
| VCEL | Sell | VERICEL CORP | $42,250,000 | +3.6% | 3,057,161 | -31.3% | 1.23% | -4.9% |
| BKD | Sell | BROOKDALE SR LIVING INC | $41,037,000 | -28.5% | 13,910,899 | -24.4% | 1.20% | -34.4% |
| ALEC | Sell | ALECTOR INC | $40,986,000 | -2.3% | 1,676,997 | -3.6% | 1.19% | -10.4% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $40,841,000 | +53.9% | 261,765 | +42.4% | 1.19% | +41.2% |
| XLRN | Buy | ACCELERON PHARMA INC | $40,168,000 | +30.3% | 421,619 | +22.9% | 1.17% | +19.6% |
| VIVO | New | MERIDIAN BIOSCIENCE INC | $38,731,000 | – | 1,663,000 | +100.0% | 1.13% | – |
| XENT | Sell | INTERSECT ENT INC | $34,891,000 | +6.7% | 2,576,879 | -6.6% | 1.02% | -2.0% |
| EDIT | EDITAS MEDICINE INC | $34,279,000 | +49.2% | 1,158,841 | 0.0% | 1.00% | +36.9% | |
| ARVN | Sell | ARVINAS INC | $33,830,000 | -30.8% | 1,008,656 | -16.8% | 0.98% | -36.5% |
| GKOS | Buy | GLAUKOS CORP | $33,579,000 | +110.1% | 874,000 | +68.7% | 0.98% | +92.9% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $31,620,000 | +18.1% | 405,386 | -11.5% | 0.92% | +8.4% |
| FATE | Sell | FATE THERAPEUTICS INC | $31,352,000 | -12.7% | 913,775 | -43.5% | 0.91% | -19.9% |
| SILK | Sell | SILK RD MED INC | $31,208,000 | -26.5% | 744,998 | -44.7% | 0.91% | -32.5% |
| ISEE | Buy | IVERIC BIO INC | $29,414,000 | +277.1% | 5,767,409 | +154.4% | 0.86% | +245.6% |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $28,921,000 | +7.7% | 24,877,000 | 0.0% | 0.84% | -1.2% | ||
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $28,538,000 | +21.8% | 6,545,500 | +5.8% | 0.83% | +11.7% |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $26,260,000 | -12.4% | 873,890 | -8.4% | 0.76% | -19.6% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $25,183,000 | +3.8% | 421,679 | -28.5% | 0.73% | -4.8% |
| GBIO | New | GENERATION BIO CO | $24,911,000 | – | 1,186,215 | +100.0% | 0.72% | – |
| RNA | New | AVIDITY BIOSCIENCES INC | $24,784,000 | – | 877,011 | +100.0% | 0.72% | – |
| ADCT | New | ADC THERAPEUTICS SA | $23,405,000 | – | 500,000 | +100.0% | 0.68% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $22,627,000 | +10.8% | 5,154,155 | -1.1% | 0.66% | +1.7% |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $22,598,000 | +69.0% | 536,001 | 0.0% | 0.66% | +55.2% | |
| AHCO | Sell | ADAPTHEALTH CORP | $22,368,000 | -91.9% | 1,389,341 | -91.9% | 0.65% | -92.5% |
| LGVWU | New | LONGVIEW ACQUISITION CORPunit 99/99/9999 | $22,220,000 | – | 2,200,000 | +100.0% | 0.65% | – |
| FUSN | New | FUSION PHARMACEUTICALS INC | $21,960,000 | – | 1,257,000 | +100.0% | 0.64% | – |
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $21,894,000 | +14.6% | 20,000,000 | 0.0% | 0.64% | +5.3% | ||
| MOH | Sell | MOLINA HEALTHCARE INC | $21,401,000 | -7.2% | 120,245 | -27.1% | 0.62% | -14.9% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $21,353,000 | -29.0% | 1,416,000 | -56.5% | 0.62% | -34.8% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $21,235,000 | +128.2% | 4,456,519 | -4.2% | 0.62% | +109.5% |
| VAPO | Sell | VAPOTHERM INC | $21,199,000 | +102.2% | 517,167 | -7.1% | 0.62% | +85.3% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $20,877,000 | – | 186,000 | +100.0% | 0.61% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $20,537,000 | +10.3% | 179,885 | -25.7% | 0.60% | +1.2% |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $20,508,000 | – | 650,000 | +100.0% | 0.60% | – |
| New | JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $19,588,000 | – | 20,000,000 | +100.0% | 0.57% | – | |
| SLQT | New | SELECTQUOTE INC | $18,998,000 | – | 750,000 | +100.0% | 0.55% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $17,898,000 | – | 1,013,495 | +100.0% | 0.52% | – |
| ARDX | Sell | ARDELYX INC | $17,726,000 | +1.1% | 2,561,554 | -16.9% | 0.52% | -7.2% |
| New | XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $17,732,000 | – | 18,000,000 | +100.0% | 0.52% | – | |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $17,412,000 | -14.1% | 833,895 | -59.8% | 0.51% | -21.2% |
| New | NEVRO CORPnote 2.750% 4/0 | $16,438,000 | – | 12,000,000 | +100.0% | 0.48% | – | |
| NTRA | Sell | NATERA INC | $16,157,000 | -58.9% | 324,038 | -75.4% | 0.47% | -62.2% |
| SIEN | Sell | SIENTRA INC | $16,110,000 | +91.5% | 4,162,804 | -1.5% | 0.47% | +75.7% |
| LUMO | LUMOS PHARMA INC | $15,437,000 | +94.0% | 936,169 | 0.0% | 0.45% | +77.9% | |
| CERS | CERUS CORP | $14,551,000 | +41.9% | 2,204,700 | 0.0% | 0.42% | +30.5% | |
| TARA | New | PROTARA THERAPEUTICS INC | $12,686,000 | – | 432,670 | +100.0% | 0.37% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $12,175,000 | -34.0% | 188,490 | -54.4% | 0.36% | -39.4% |
| IMRA | Sell | IMARA INC | $11,715,000 | +46.2% | 424,000 | -15.2% | 0.34% | +34.3% |
| KROS | New | KEROS THERAPEUTICS INC | $11,253,000 | – | 300,000 | +100.0% | 0.33% | – |
| OMI | New | OWENS & MINOR INC NEW | $11,255,000 | – | 1,477,000 | +100.0% | 0.33% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $10,985,000 | +668.2% | 845,000 | +447.3% | 0.32% | +611.1% |
| ORIC | New | ORIC PHARMACEUTICALS INC | $10,119,000 | – | 300,000 | +100.0% | 0.30% | – |
| APLT | APPLIED THERAPEUTICS INC | $10,063,000 | +10.6% | 278,359 | 0.0% | 0.29% | +1.4% | |
| ITMR | ITAMAR MED LTDsponsored ads | $9,284,000 | +57.9% | 499,136 | 0.0% | 0.27% | +44.4% | |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $8,455,000 | +26.3% | 3,178,551 | -7.4% | 0.25% | +16.0% |
| SEM | Sell | SELECT MED HLDGS CORP | $8,322,000 | -47.8% | 565,000 | -46.8% | 0.24% | -52.2% |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $7,631,000 | – | 825,000 | +100.0% | 0.22% | – |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $7,295,000 | -78.7% | 494,216 | -80.5% | 0.21% | -80.5% |
| AKUS | New | AKOUOS INC | $7,156,000 | – | 318,034 | +100.0% | 0.21% | – |
| ARYBU | New | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $5,798,000 | – | 500,000 | +100.0% | 0.17% | – |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $5,281,000 | -33.8% | 1,970,687 | -51.1% | 0.15% | -39.1% |
| CABA | Sell | CABALETTA BIO INC | $5,172,000 | -44.8% | 464,252 | -63.9% | 0.15% | -49.3% |
| STIM | Buy | NEURONETICS INC | $3,268,000 | +9.8% | 1,693,317 | +7.5% | 0.10% | +1.1% |
| New | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $2,516,000 | – | 3,500,000 | +100.0% | 0.07% | – | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $1,839,000 | – | 357,101 | +100.0% | 0.05% | – |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $1,110,000 | -95.3% | 53,043 | -96.8% | 0.03% | -95.7% |
| ELGXQ | ENDOLOGIX INC | $764,000 | +16.5% | 950,000 | 0.0% | 0.02% | +4.8% | |
| NEOS | NEOS THERAPEUTICS INC | $220,000 | -8.7% | 320,993 | 0.0% | 0.01% | -25.0% | |
| WINT | New | WINDTREE THERAPEUTICS INC | $141,000 | – | 20,148 | +100.0% | 0.00% | – |
| KMPH | Exit | KEMPHARM INC | $0 | – | -418,613 | -100.0% | -0.00% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -380,300 | -100.0% | -0.02% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -168,871 | -100.0% | -0.03% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -167,637 | -100.0% | -0.06% | – |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -214,789 | -100.0% | -0.07% | – |
| Exit | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $0 | – | -3,500,000 | -100.0% | -0.09% | – | |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -1,268,946 | -100.0% | -0.24% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -963,212 | -100.0% | -0.26% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -937,983 | -100.0% | -0.31% | – |
| TARA | Exit | ARTARA THERAPEUTICS INC | $0 | – | -432,670 | -100.0% | -0.32% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -670,367 | -100.0% | -0.34% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -138,874 | -100.0% | -0.44% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -155,380 | -100.0% | -0.47% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -945,718 | -100.0% | -0.54% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -1,124,879 | -100.0% | -0.56% | – |
| Exit | JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $0 | – | -20,000,000 | -100.0% | -0.61% | – | |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -151,779 | -100.0% | -0.64% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -235,000 | -100.0% | -0.73% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -87,000 | -100.0% | -0.74% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -412,867 | -100.0% | -0.84% | – |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -61,000,000 | -100.0% | -1.62% | – | |
| ABMD | Exit | ABIOMED INC | $0 | – | -376,000 | -100.0% | -1.73% | – |
| Exit | DEXCOM INCnote 0.750%12/0 | $0 | – | -34,000,000 | -100.0% | -1.87% | – | |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -4,037,305 | -100.0% | -1.99% | – |
| Exit | NUVASIVE INCnote 2.250% 3/1 | $0 | – | -85,000,000 | -100.0% | -2.82% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.